Perineural Platelet-Rich Plasma for Diabetic Neuropathic Pain, Could It Make a Difference? M Hassanien, A Elawamy, EZ Kamel, WA Khalifa, GM Abolfadl, ... Pain Medicine 21 (4), 757-765, 2020 | 29 | 2020 |
Value of platelet distribution width and mean platelet volume in disease activity score of rheumatoid arthritis SAA Khaled, E NasrEldin, YS Makarem, HFF Mahmoud Journal of Inflammation Research, 595-606, 2020 | 24 | 2020 |
Peripheral cells from patients with systemic sclerosis disease co-expressing M1 and M2 monocyte/macrophage surface markers: Relation to the degree of skin involvement ME Mohamed, RM Gamal, MA El-Mokhtar, AT Hassan, HSM Abozaid, ... Human Immunology 82 (9), 634-639, 2021 | 14 | 2021 |
Vitamin D in active systemic lupus erythematosus and lupus nephritis: a forgotten player MK Khairallah, YS Makarem, MA Dahpy The Egyptian Journal of Internal Medicine 32, 1-9, 2020 | 9 | 2020 |
Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios as noninvasive predictors for renal involvement in systemic lupus erythematosus in health clinics MM Soliman, YS Makarem, AA El Wafaa, MKA Khairallah The Egyptian Journal of Internal Medicine 31, 927-933, 2019 | 4 | 2019 |
Between Academia and Clinical Application: Where is Platelet Indices in Disease Activity Score of Rheumatoid Arthritis? SA Khaled, E NasrELdin, Y Makarem BRITISH JOURNAL OF HAEMATOLOGY 185, 161-161, 2019 | 3 | 2019 |
Frequency and impact of DHODH, ABCG2 and CYP2C19 SNPs on the therapeutic efficacy, tolerability and toxicity of leflunomide YS Makarem, MS Hareedy, M Hassanien, EA Ahmed, HF Hetta, ... Pharmacogenomics 22 (18), 1201-1209, 2021 | 2 | 2021 |
Effect of Local Injection of 1, 25 Dihydroxycholecalciferol on Bone Remodeling in Uremic Rabbit Model MK Khairallah, A El-Rady, M Nessren, YS Makarem, MA Dahpy, ... The Egyptian Journal of Hospital Medicine 80 (3), 1116-1125, 2020 | 2 | 2020 |
Anti-C1q antibodies as a marker for disease activity in systemic lupus erythematosus and lupus nephritis EAH Omran, NM Ismail, E Mosad, YS Hussein Journal of Current Medical Research and Practice 1 (3), 47-53, 2016 | 2 | 2016 |
CXCL10 as a biomarker of interstitial lung disease in patients with rheumatoid arthritis YS Makarem, EA Ahmed, M Makboul, S Farghaly, N Mostafa, ... Reumatología Clínica (English Edition) 20 (1), 1-7, 2024 | 1 | 2024 |
CXCL10 como biomarcador de enfermedad pulmonar intersticial en pacientes con artritis reumatoide YS Makarem, EA Ahmed, M Makboul, S Farghaly, N Mostafa, ... Reumatología Clínica 20 (1), 1-7, 2024 | | 2024 |
Study the Relationship of MDCT Staging in Disease Extent with the Systemic Sclerosis Disease Parameters AM Ghandour, RM Gamal, GS Eldein, AM Gamal, E El-Hakeim, ... Reumatología Clínica (English Edition) 18 (10), 597-602, 2022 | | 2022 |
Frequency and risk factors of frailty in nondialyzable chronic kidney disease geriatric patients MK Khairallah, MA Haridi, MM Shehab, YS Makarem, SA Gomaa Journal of Current Medical Research and Practice 7 (2), 145-150, 2022 | | 2022 |
Estudiar la relación de la estadificación de la TCMD en la extensión de la enfermedad con los parámetros de la enfermedad de esclerosis sistémica AM Ghandour, RM Gamal, GS Eldein, AM Gamal, E El-Hakeim, MA Galal, ... Reumatología Clínica 18 (10), 597-602, 2022 | | 2022 |
VITAMIN D DEFICIENCY AND ANTI-C1Q ANTIBODIES AS MARKERS FOR DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS EAH Omran, NM Ismail, E Mosad, YS Hussein CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 34 (4), S58-S59, 2016 | | 2016 |